Related Experiment Videos
Fatal hepatitis B in infant born to a HBsAg carrier with HBeAb
Archives of Disease in Childhood
|March 1, 1985
Insights
Fulminant hepatic failure occurred in an infant born to a hepatitis B e antibody positive mother. Infants born to hepatitis B e antigen positive mothers receive immunoprophylaxis, unlike those born to mothers who are hepatitis B e antibody positive.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis B virus (HBV) infection poses risks to newborns.
- Maternal HBV status influences infant immunoprophylaxis strategies.
- Hepatitis B e antigen (HBeAg) and antibody (HBeAb) are key serological markers.
Observation:
- An 11-week-old infant developed fulminant hepatic failure.
- The infant's mother was hepatitis B surface antigen (HBsAg) positive.
- The mother was HBeAg negative and HBeAb positive.
Findings:
- Standard immunoprophylaxis protocols may not adequately protect infants born to HBeAb-positive mothers.
- This case highlights a potential gap in current hepatitis B prevention strategies for newborns.
- Fulminant hepatic failure in an infant suggests severe HBV transmission or pathogenesis.
Implications:
- Re-evaluation of immunoprophylaxis guidelines for infants born to HBeAb-positive mothers is warranted.
- Further research is needed to understand the specific risks associated with HBeAb positivity during pregnancy.
- This case underscores the importance of comprehensive maternal screening and tailored infant management for hepatitis B prevention.
Abstract:
Fulminant hepatic failure occurred in an 11 week old baby of a Caucasian mother who was hepatitis B surface antigen positive, B e antigen negative, and B e antibody positive. Infants of hepatitis B e antigen positive mothers receive immunoprophylaxis against hepatitis, unlike those born to mothers who are B e antibody positive.